(Press-News.org) Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine
A new study from Stanford researchers published in PLoS Medicine makes the case that a combination of methadone substitution therapy and anti-retroviral treatment would have the greatest effect on reducing new infections and improving quality of life in a region where HIV is spreading rapidly among intravenous drug users.
In the past decade, an epidemic of HIV has swept through Ukraine, fueled mostly by intravenous drug use. Of Ukraine's approximately 390,000 intravenous drug users as many as half are HIV-infected. Researchers at Stanford and Veterans Affairs Palo Alto Health Care System have demonstrated, using a cost-effectiveness modeling study, that the most effective way to combat the spreading disease is a combined program of drug substitution – providing methadone for opiate users, for instance – and anti-retroviral therapy for those already infected with HIV.
"HIV is spreading in Eastern Europe more quickly than in any other part of the world," said Margaret Brandeau, the Coleman F. Fung Professor of Engineering at Stanford University and senior author of the study. "Our study shows that substitution therapy for injection drug users is an inexpensive and effective means of curbing HIV transmission in the region."
With no further intervention, the study predicts that HIV prevalence will reach 67.2 percent in intravenous drug users in 20 years. The authors further show that providing drug-substitution to just 25 percent of intravenous drug users today could lower that figure considerably.
"Not only does drug substitution therapy work, but it is remarkably cost-effective when you consider total costs of treating and caring for a growing HIV-infected community," said lead author Sabina Alistar.
"Providing effective drug substitution therapy and HIV antiretroviral therapy together to the injection-drug-using community protects the entire population – it actually prevents more infections in non-drug users than in the drug-using community," said Douglas K. Owens, co-author and a senior investigator at the VA Palo Alto Health Care System and professor of medicine at Stanford University.
###
Funding: This research was supported by Grant Number R01DA15612 from the National Institute on Drug Abuse. Sabina S. Alistar is also supported by a Stanford Graduate Fellowship. Dr. Owens is supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: DKO received an honorarium from Quintiles to prepare a continuing medical education lecture about HIV screening. No other competing interests have been declared.
Citation: Alistar SS, Owens DK, Brandeau ML (2011) Effectiveness and Cost Effectiveness of Expanding Harm Reduction and Antiretroviral Therapy in a Mixed HIV Epidemic: A Modeling Analysis for Ukraine. PLoS Med 8(3): e1000423. doi:10.1371/journal.pmed.1000423
CONTACT:
Margaret Brandeau is Coleman F. Fung Professor of Management Science and Engineering, Stanford University: 650.725.1623, brandeau@stanford.edu
Douglas K. Owens, MD, MS, is a senior investigator at the VA Palo Alto Health Care System and a Professor of Medicine and of Health Research and Policy at Stanford University, owens@stanford.edu
Sabina S. Alistar, MS, is a PhD candidate in the Department of Management Science and Engineering, ssabina@stanford.edu
Effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic
2011-03-02
ELSE PRESS RELEASES FROM THIS DATE:
Women get short shrift in many heart device studies, despite requirement
2011-03-02
Despite a long-standing requirement for medical device makers to include women in studies they submit to the Food and Drug Administration for device approval, only a few include enough women or analyze how the devices work specifically in women, according to research reported in Circulation: Cardiovascular Quality and Outcomes.
"Women and men differ in their size, bleeding tendencies, and other factors that are directly relevant to how the devices will work," said Rita F. Redberg, M.D., M.Sc., senior author of the study and professor of medicine and director of Women's ...
Answers to a rare and tragic form of epilepsy
2011-03-02
A new study offers critical insight into the biochemistry of a rare and fatal form of epilepsy known as Lafora disease, a genetic condition that typically strikes children in their teens. The disease is characterized by the buildup of a "wrecked" form of glycogen, a stored form of glucose, in the brain and specifically in neurons. It now appears those errors and the structural problems they cause are all because the enzyme that normally builds glycogen is prone to making mistakes, according to the report in Cell Metabolism.
That enzyme, known as glycogen synthase, usually ...
For some kids, corneal transplant improves vision and daily life
2011-03-02
SAN FRANCISCO–Teens, children, and even infants sometimes require corneal transplants, although most such surgeries are performed in adults. Australian researchers led by Keryn A. Williams, PhD, tracked transplant success and visual outcomes in 640 young patients who received new corneas between 1985 and 2009 and report on their work in the March issue of Ophthalmology, the journal of the American Academy of Ophthalmology.
Dr. Williams' team found that the highest rate of transplant success occurred in adolescent patients treated for keratoconus. About 86 percent of transplants ...
DREADD-ing your next meal
2011-03-02
In the face of the growing obesity epidemic, much research has focused on the neuronal control of feeding behavior. Agouti-related protein (AgRP) neurons express three proteins that have been implicated in changes in energy balance, but the studies linking AgRP neurons to feeding behavior have produced mixed results.
To directly analyze the role of AgRP neurons, Bradford Lowell and colleagues, at Beth Israel Deaconess Medical Center in Boston, used DREADD technology (designer receptors exclusively activated by designer drugs) to specifically control the activation and ...
Gene variations associated with risk of type 2 diabetes
2011-03-02
For individuals of white European descent, certain variations of the gene HMGA1 are associated with type 2 diabetes mellitus, according to a study in the March 2 issue of JAMA.
Type 2 diabetes mellitus (DM) is a common metabolic disorder that affects nearly 250 million people worldwide, and is associated with major diabetes-related complications, including retinopathy, kidney disease and cardiovascular disease. Insulin resistance in muscle, liver, and fat tissue is a major feature of most patients with type 2 DM. There is considerable evidence that heredity is a major ...
Nitric oxide does not appear to improve treatment of sickle cell pain-attacks
2011-03-02
Among patients with sickle cell disease, treatment of a vaso-occlusive crisis (characterized by episodes of severe pain) in the hospital with inhalation of nitric oxide gas for up to 3 days did not result in a shorter time to resolution of the pain, compared to patients who received placebo, according to a study in the March 2 issue of JAMA.
Vaso-occlusive crisis (VOC) is common among patients with sickle cell disease (SCD), with an average length of hospitalization during VOC of 4.5 days for children ages 10 to 14 years. As many as 20 percent of patients hospitalized ...
A small subset of normal white blood cells gives rise to a rare leukemia, study shows
2011-03-02
COLUMBUS, Ohio – New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.
The study, led by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), shows that large granular lymphocyte leukemia can occur in a small subset of white blood cells called NKT cells. NKT cells share features of immune cells called T lymphocytes and features of immune cells called natural killer (NK) cells. ...
Gene variants in autism linked to brain development
2011-03-02
New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered. While the gene alterations are individually very rare, they mostly appear to disrupt genes that play important functional roles in brain development and nerve signaling.
While an association between genomic variants in certain ...
Shark tracking reveals impressive feats of navigation
2011-03-02
Some shark species are able to navigate to specific locations up to 50km away, a new study published in the British Ecological Society's Journal of Animal Ecology has found. Re-analysing tracking data from tagged sharks, ecologists found that while some species such as blacktip reef sharks swim in a pattern known as a "random walk", others such as tiger sharks can at times hunt for prey or mates by using "directed walks", accurately navigating long distances across open ocean, often at night.
To maximise lifetime fitness, animals should optimise search patterns for finding ...
New generation of optical integrated devices for future quantum computers
2011-03-02
A research group led by scientists from the University of Bristol has demonstrated the quantum operation of new components that will enable compact circuits for future photonic quantum computers.
Quantum computers, holding the great promise of tremendous computational power for particular tasks, have been the goal of worldwide efforts by scientists for several years. Tremendous advances have been made but there is still a long way to go.
Building a quantum computer will require a large number of interconnected components – gates – which work in a similar way to the ...